Shock/SIRS/Sepsis/MODS Flashcards
Shock definition
Shock is defined as an inadequate production of energy at the cellular level
– secondary to decreased delivery of oxygen and nutrients to tissues
Cryptic shock
term cryptic shock has been used to describe ill or injured patients with high lactate concentrations without hypotension
Goal of Shock tx
aims to improve tissue perfusion and restore optimal oxygen and nutrient delivery to tissues.
Resuscitation endpoints
Normalization of arterial blood pressure
lactate concentration and central venous oxygen saturation
POCUS as a means of dynamically assessing intravascular volume
Shock fluids
shock dose is approximately 60 to 90 ml/kg in dogs and approximately 45 to 60 ml/kg in cats, which reflects the approximate blood volumes in each species
– A common recommendation in small animals is to begin shock treatment using a bolus of 10 to 20 ml/kg administered over 15 to 30 minutes
Isotonic fluids for Shock boluses
– Rapid redistribution with short-lived intravascular volume expansion effect.
– Caution with use in patients with decreased colloid osmotic pressure or increased vascular permeability due to increased risk of pulmonary and interstitial edema
Normal Saline, LRS, Plyte, Norm-R
Synthetic colloids for shock boluses
Does: 2–5 ml/kg IV over 10–30 minutes
– Sustained intravascular volume expansion.
Increased risk of coagulation disturbances with use of large doses.
– May cause or exacerbate preexisting acute kidney injury
HES, Vetstarch
Hypertonic solutions for shock boluses
Dose: 3–5 ml/kg of 7%–7.5% NaCl solution over 10–20 minutes
– Monitor electrolytes, particularly sodium. Use with caution in chronic hyponatremia.
– Can exacerbate interstitial volume depletion in dehydrated patients.
– Good for small-volume resuscitation, particularly in septic shock, hemorrhagic shock, and traumatic brain injury.
3% HTS, 7.5% HTS
Blood products for shock boluses
10–20 ml/kg given IV over 2–4 hours (can be given faster in rapidly decompensating patients up to a rate of 1.5 ml/kg/min over 15–20 min
– Ideal for patients presenting in acute hemorrhagic shock
–
Canine and feline pRBCs
Canine and feline FFP
Canine and feline fresh whole blood (where donors available)
Adverse effects of aggressive crystalloid resuscitation
– patients with severe hypoproteinemia or kidney or cardiac dz
– Bc crystalloids redistribute into the interstitium, organ edema can occur and may be life threatening
– Pulmonary edema and ALI are among the most commonly seen adverse effects of shock resuscitation, particularly in patients with increased vascular permeability secondary to systemic inflammation or sepsis.
GIT effects of aggressive crystalloid fluid therapy
decreased motility, increased intestinal permeability predisposing the patient to bacterial translocation, and increased risk for abdominal compartment syndrome
Cardiac effect from aggressive crystalloid fluid therapy
– increased risk of ventricular arrhythmias, disruption of cardiac contractility, and decreased CO
– demonstrated by Starling’s myocardial performance curve; when beyond a designated point on the curve, further increases in end-diastolic volume cause a decrease in CO
Coag effects of aggressive crystalloid fluid therapy
Coagulation disturbances can also occur as a result of dilution of coagulation factors and decreased blood viscosity; however, these effects are significantly less than changes caused by synthetic colloids
Effects of aggressive resuscitation with crystalloids on endothelial glycocalyx
“Overzealous resuscitation with crystalloids has also been shown to negatively impact the health of the endothelial glycocalyx.
Recent studies have demonstrated that the volume of crystalloids administered in patients with septic shock is independently associated with the degree of glycocalyx degradation.”
Synthetic colloids
– increase the colloid osmotic pressure of serum, creating a force that opposes the hydrostatic pressure in the vasculature and helps retain fluid in the vascular space
Adverse effects of Synthetic Colloids
Coag adveserve effects of Synthetic Colloids
All colloidal plasma substitutes are known to interfere with the physiologic mechanisms of hemostasis either through a nonspecific effect correlated to the degree of hemodilution or through specific actions of these macromolecules on platelet function, coagulation proteins, and the fibrinolytic system.
– decreases in the activity of von Willebrand’s factor and its associated factor VIII and ristocetin cofactor activities, as well as some degree of platelet dysfunction
What dose of Synthetic Colliods is know to cause coag abnormalities?
that the administration of more than 20 ml/kg/day of hetastarch in animals can cause coagulation derangements
Hypertonic solutions
crystalloid solution is any saline solution that has an effective osmolarity exceeding that of normal plasma
– causes intravascular volume expansion due to the osmotic gradient generated by the sudden, dramatic increase in plasma osmolarity after administration
Other Advantagous of Hypertonic solutions
#3
– immunomodulatory effects, such as decreased neutrophil activation and adherence, stimulation of lymphocyte proliferation, and inhibition of proinflammatory cytokine production by macrophages.
– also improves the rheologic properties of circulating blood, reduces endothelial cell swelling, and helps reduce intracranial pressure in patients with traumatic brain injury
– improves myocardial function and causes coronary vasodilation, thereby improving overall cardiac function
Adverse effects of Hypertonic Fluids
#4
= hypernatremia and hyperchloremia
– risk for hypernatremia-induced osmotic demyelination syndrome
cautiously in patients with preexisting cardiac or pulmonary abnormalities because the increase in intravascular volume and hydrostatic pressure may lead to volume overload or pulmonary edema.
– can also cause significant interstitial (and intravascular) volume depletion, particularly in patients that are already dehydrated.
Albumin
– maintenance of colloid osmotic pressure and endothelial integrity, wound healing, metabolic and acid-base functions, coagulation, and free radical scavenging.
– often low in critically ill patients because of loss, vascular leak, third-spacing, and decreased production as a result of shifting of hepatic production toward acute-phase proteins.
Blood products
(whole blood, fresh frozen plasma [FFP], or packed red blood cells [pRBCs])
– hemorrhagic shock secondary to trauma, nontraumatic hemoabdomen, gastrointestinal bleeding, rodenticide intoxication, or other primary or secondary coagulopathies
– FWB transfusions carry the benefit of increased levels of clotting factors, fibrinogen, and platelets compared with component therapy
Hypotensive resuscitation
Restoration of a lower-than-normal systolic blood pressure (approximately 80 to 90 mm Hg) helps facilitate control of hemorrhage and reduces the risk of rebleeding but ensures preserved blood flow to vital organs such as the kidney and GI tract.
– temporary solution and is only meant to bridge the gap between presentation and definitive hemostatic control (usually via surgical intervention)
Fluid challenge
– administration of fluids to patients that are hemodynamically unstable in order to assess their response to fluid therapy
– helps guide therapy, particularly when hypovolemia may be subtle, while minimizing the risk of volume overload that can occur as a result of overzealous or unnecessary fluid therapy.
Urosepsis
sepsis associated with a complicated urinary tract infection (UTI).
– infection can be the kidney, bladder, prostate, or genital tract
– pyometra, prostatic abscessation or suppuration, testicular abscessation, renal abscessation and vaginal abscessation
uncommon in vetmed
local host defense mechanisms typically prevent ascending UTIs:
x7
- normal micturition,
- extensive renal blood supply,
- normal urinary tract anatomy (i.e., urethral lengthhigh pressure zones within the urethra),
- urethral and ureteral peristalsis,
- mucosal defense barriers,
- antimicrobial properties of the urine,
- systemic immunocompetence
Most common uropathogen
E. coli
laboratory changes with urosepsis
specifically related to the urinary tract, including azotemia, an active urine sediment and a positive urine bacterial culture
Pyelonephritis causing Urosepsis
– one or both kidneys may be enlarged and painful, and the animal may have signs of polyuria, polydipsia, and vomiting. Azotemia may be present and blood work often reveals a neutrophilic leukocytosis with a left shift and a metabolic acidosis.
–urinalysis may reveal impaired urine concentrating ability, bacteriuria, pyuria, proteinuria, hematuria, and/or granular casts